Class information for:
Level 1: CYTOKINE INDUCED KILLER CELLS//CIK CELLS//CYTOKINE INDUCED KILLER CELL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
22281 330 35.7 88%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
151 22214 IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CYTOKINE INDUCED KILLER CELLS Author keyword 213 88% 30% 99
2 CIK CELLS Author keyword 33 74% 8% 25
3 CYTOKINE INDUCED KILLER CELL Author keyword 16 64% 5% 16
4 CIK Author keyword 15 68% 4% 13
5 CYTOKINE INDUCED KILLER Author keyword 5 60% 2% 6
6 CYTOKINE INDUCED KILLER CIK CELLS Author keyword 5 60% 2% 6
7 POLIKLIN S HAMATOL ONKOL Address 4 75% 1% 3
8 PRECONDITIONING CHEMOTHERAPY Author keyword 3 100% 1% 3
9 CD3CD56 CELLS Author keyword 2 67% 1% 2
10 CENTRUM SOMAT GENTHER IE Address 2 67% 1% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CYTOKINE INDUCED KILLER CELLS 213 88% 30% 99 Search CYTOKINE+INDUCED+KILLER+CELLS Search CYTOKINE+INDUCED+KILLER+CELLS
2 CIK CELLS 33 74% 8% 25 Search CIK+CELLS Search CIK+CELLS
3 CYTOKINE INDUCED KILLER CELL 16 64% 5% 16 Search CYTOKINE+INDUCED+KILLER+CELL Search CYTOKINE+INDUCED+KILLER+CELL
4 CIK 15 68% 4% 13 Search CIK Search CIK
5 CYTOKINE INDUCED KILLER 5 60% 2% 6 Search CYTOKINE+INDUCED+KILLER Search CYTOKINE+INDUCED+KILLER
6 CYTOKINE INDUCED KILLER CIK CELLS 5 60% 2% 6 Search CYTOKINE+INDUCED+KILLER+CIK+CELLS Search CYTOKINE+INDUCED+KILLER+CIK+CELLS
7 PRECONDITIONING CHEMOTHERAPY 3 100% 1% 3 Search PRECONDITIONING+CHEMOTHERAPY Search PRECONDITIONING+CHEMOTHERAPY
8 CD3CD56 CELLS 2 67% 1% 2 Search CD3CD56+CELLS Search CD3CD56+CELLS
9 CIKS 2 50% 1% 3 Search CIKS Search CIKS
10 CIK CELL 2 43% 1% 3 Search CIK+CELL Search CIK+CELL

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CIK CELLS 130 91% 16% 53
2 IMMUNOLOGICAL EFFECTOR CELLS 96 93% 11% 37
3 INDUCED KILLER CELLS 31 43% 17% 55
4 CD3CD56 KILLER CELLS 3 100% 1% 3
5 CD3CD56 CYTOTOXIC CELLS 2 67% 1% 2
6 HLA BARRIERS 2 67% 1% 2
7 ALLOGENEIC TRANSPLANT 2 50% 1% 3
8 NONCURATIVE RESECTION 1 50% 1% 2
9 CYTOTOXIC CAPACITY 1 50% 0% 1
10 INDUCED IMMUNOGENIC MODULATION 1 50% 0% 1

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors 2012 41 72 69%
Cytokine-induced killer cells promote antitumor immunity 2013 32 74 43%
An update on new adoptive immunotherapy strategies for solid tumors with cytokine-induced killer cells 2014 4 56 77%
New adoptive immunotherapy strategies for solid tumours with CIK cells 2012 18 31 90%
Combining cytokine-induced killer cells with vaccination in cancer immunotherapy: More than one plus one? 2011 18 33 85%
Cytokine-Induced NK-Like T Cells: From Bench to Bedside 2010 28 42 62%
T-cell-associated cellular immunotherapy for lung cancer 2015 2 64 17%
Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies 2014 2 38 82%
Review of Chinese clinical trials on CIK cell treatment for malignancies 2012 13 21 81%
Combined immunotherapy with dendritic cells and cytokine-induced killer cells for malignant tumors: A systematic review and meta-analysis 2014 2 32 78%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 POLIKLIN S HAMATOL ONKOL 4 75% 0.9% 3
2 CENTRUM SOMAT GENTHER IE 2 67% 0.6% 2
3 GERIATR HEMATOL 1 21% 1.8% 6
4 ONCOL SCI CELL THER Y CANC 1 100% 0.6% 2
5 SJ TECHNOVILLE 1 100% 0.6% 2
6 YUNNAN CANC HOSP 1 50% 0.6% 2
7 USC HEMATOL 1 24% 1.2% 4
8 CELL THER Y IL 1 21% 1.2% 4
9 YANAN AFFILIATED HOSP 1 25% 0.9% 3
10 CELLULAR THER Y G LANZANI 1 21% 0.9% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000133835 CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//CHIMERIC IMMUNE RECEPTOR
2 0.0000120917 NKG2D//NKG2D LIGANDS//MICB
3 0.0000110914 MHC NONRESTRICTED CYTOTOXICITY//HISTAMINE DIHYDROCHLORIDE//BOWYER ONCOL
4 0.0000091141 BELAGENPUMATUCEL L//SRL172//PA MSHA
5 0.0000081828 TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//AUTOLYMPHOCYTE THERAPY
6 0.0000070004 FOXP3//TUMOR INFILTRATING LYMPHOCYTES//INTEGRAT CANC IMMUNOL
7 0.0000069327 DENDRITIC CELLS//DENDRITIC CELL//TUMOR LYSATE
8 0.0000065647 BISPECIFIC ANTIBODIES//CATUMAXOMAB//TRIFUNCTIONAL ANTIBODY
9 0.0000065377 ACUTE REJECTION REACTION//TUMOR ANGIOGENESIS//E S 8
10 0.0000052475 BIOCHIM GEN GLYCOBIOL//3 3 DIOCTADECYLOXACARBOCYANINE PERCHLORATE//CONJUGATE FORMATION